Ferrous sulfate: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 145: Line 145:
| ATCCode_suffix = AA07
| ATCCode_suffix = AA07
| UNNumber = 3077
| UNNumber = 3077
| SMILES = [O-]S(=O)(=O)[O-].[Fe+2]
| SMILES = {O-S(=O)(=O){O-}.{Fe+2}
| SMILES_Ref = {{smilescite}}
| SMILES_Ref = {{smilescite}}
| InChI = 1/Fe.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2
| InChI = 1/Fe.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2

Revision as of 00:25, 10 February 2015

{{DrugProjectFormSinglePage |authorTag=Adeel Jamil, M.D. [1] |OTC=Yes |genericName=Ferrous sulfate |aOrAn=a |drugClass=essential minerals |indicationType=treatment |indication=iron deficiency and iron deficiency anemia |adverseReactions=constipation, darkened colored stools, diarrhea, nausea and stomach upset. |blackBoxWarningTitle=ConditionName: |blackBoxWarningBody=ConditionName:

  • Content


|fdaLIADAdult======Iron Supplement Therapy=====

Dosing Information

  • Adults and children 12 years and over : take 1 tablet daily or as directed by a doctor


|offLabelAdultGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Ferrous sulfate in adult patients.

|offLabelAdultNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Ferrous sulfate in adult patients.


|fdaLIADPed=* Children under 12 years : consult a physician.


|offLabelPedGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Ferrous sulfate in pediatric patients.

|offLabelPedNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Ferrous sulfate in pediatric patients.

|contraindications=There is limited information regarding Contraindications of Ferrous sulfate in pediatric patients. |warnings=* Do not exceed recommended dosage. The treatment of any anemic condition should be under the advice and supervision of a physician. Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within tow hours of each other. Occasional gastrointestinal discomfort (such as nausea) may be minimized by taking with meals. Iron-containing products may occasionally cause constipation or diarrhea.

  • If are pregnant or nursing a baby, seek the advise of a health professional before using this products.
  • Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

|clinicalTrials=There is limited information regarding Clinical Trial Experience of Ferrous sulfate in the drug label. |postmarketing=There is limited information regarding Postmarketing Experience of Ferrous sulfate in the drug label. |drugInteractions=There is limited information regarding Drug Interactions of Ferrous sulfate in the drug label. |useInPregnancyFDA=* Pregnancy Category |useInPregnancyAUS=* Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Ferrous sulfate in women who are pregnant. |useInLaborDelivery=There is no FDA guidance on use of Ferrous sulfate during labor and delivery. |useInNursing=There is no FDA guidance on the use of Ferrous sulfate with respect to nursing mothers. |useInPed=There is no FDA guidance on the use of Ferrous sulfate with respect to pediatric patients. |useInGeri=There is no FDA guidance on the use of Ferrous sulfate with respect to geriatric patients. |useInGender=There is no FDA guidance on the use of Ferrous sulfate with respect to specific gender populations. |useInRace=There is no FDA guidance on the use of Ferrous sulfate with respect to specific racial populations. |useInRenalImpair=There is no FDA guidance on the use of Ferrous sulfate in patients with renal impairment. |useInHepaticImpair=There is no FDA guidance on the use of Ferrous sulfate in patients with hepatic impairment. |useInReproPotential=There is no FDA guidance on the use of Ferrous sulfate in women of reproductive potentials and males. |useInImmunocomp=There is no FDA guidance one the use of Ferrous sulfate in patients who are immunocompromised.

|administration=* Oral

  • Intravenous

|monitoring=There is limited information regarding Monitoring of Ferrous sulfate in the drug label.

  • Description

|IVCompat=There is limited information regarding IV Compatibility of Ferrous sulfate in the drug label.

|overdose=There is limited information regarding Chronic Overdose of Ferrous sulfate in the drug label.


|drugBox=

Template:Chembox E numberTemplate:Chembox RTECSTemplate:Chembox UNNumber
Iron(II) sulfate
Skeletal formula of iron(II) sulfate
Sample of iron(II) sulfate anhydrous
Names
IUPAC name
Iron(II) sulfate
Other names
Ferrous sulfate, Green vitriol, Iron vitriol, Copperas, Melanterite, Szomolnokite
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
UNII
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

{{#subobject:

 |Page Name=Ferrous sulfate
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Ferrous sulfate
 |Label Name=Ferrous sulfate11.png

}}

{{#subobject:

 |Label Page=Ferrous sulfate
 |Label Name=Ferrous sulfate11.png

}}